Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study.

Zoe Arvanitakis,Robin L. Brey,Jacob H. Rand,Julie A. Schneider,Sue Leurgans,Lei Yu,Aron S. Buchman,Konstantinos Arfanakis,Debra A. Fleischman,Patricia A. Boyle,David A. Bennett,Steven R. Levine

Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study.

2013

Zoe Arvanitakis
Robin L. Brey
Jacob H. Rand
Julie A. Schneider
Sue Leurgans
Lei Yu
Aron S. Buchman
Konstantinos Arfanakis
Debra A. Fleischman
Patricia A. Boyle
David A. Bennett
Steven R. Levine

The overall goal of the Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging study is to test the hypothesis that antiphospholipid antibodies (aPL) are associated with

Keywords:

Physical therapy
Movement disorders
Dementia
Magnetic resonance imaging
Medicine
Cohort study
Cognition
Cerebral infarction
Stroke
Internal medicine
Psychiatry
Pathological
Cardiology
Biomarker (medicine)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations